TY - JOUR AU - Mabry, R. M. AU - Reeves, M. M. AU - Eakin, E. G. AU - Owen, N. PY - 2010 DA - 2010// TI - Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review JO - Diabet Med VL - 27 UR - https://doi.org/10.1111/j.1464-5491.2010.02998.x DO - 10.1111/j.1464-5491.2010.02998.x ID - Mabry2010 ER - TY - JOUR AU - AlSuwaidi, J. AU - Zubaid, M. AU - El-Menyar, A. A. PY - 2010 DA - 2010// TI - Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six middle eastern countries JO - J Clin Hypertens. VL - 12 UR - https://doi.org/10.1111/j.1751-7176.2010.00371.x DO - 10.1111/j.1751-7176.2010.00371.x ID - AlSuwaidi2010 ER - TY - JOUR AU - Al-Rasadi, K. AU - Sulaiman, K. AU - Panduranga, P. AU - Al-Zakwani, I. PY - 2011 DA - 2011// TI - Prevalence, characteristics, and in-hospital outcomes of metabolic syndrome among acute coronary syndrome patients from Oman JO - Angiology. VL - 62 UR - https://doi.org/10.1177/0003319710382419 DO - 10.1177/0003319710382419 ID - Al-Rasadi2011 ER - TY - JOUR AU - Lakka, H. M. AU - Laaksonen, D. E. AU - Lakka, T. A. PY - 2002 DA - 2002// TI - The metabolic syndrome and total and cardiovascular disease mortality in middle aged men JO - JAMA VL - 288 UR - https://doi.org/10.1001/jama.288.21.2709 DO - 10.1001/jama.288.21.2709 ID - Lakka2002 ER - TY - JOUR AU - Grundy, S. M. AU - Cleeman, J. I. AU - Daniels, S. R. PY - 2005 DA - 2005// TI - Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement JO - Circulation VL - 112 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.169404 DO - 10.1161/CIRCULATIONAHA.105.169404 ID - Grundy2005 ER - TY - JOUR AU - IIanne-Parikka, P. AU - Eriksson, J. G. AU - Lindstrom, J. PY - 2008 DA - 2008// TI - Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish diabetes prevention study JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc07-1117 DO - 10.2337/dc07-1117 ID - IIanne-Parikka2008 ER - TY - JOUR AU - Arafah, M. AU - Al-Hinai, A. T. AU - Al Mahmeed, W. A. PY - 2014 DA - 2014// TI - Centralized pan-middle east survey on the undertreatment of hypercholesterolemia: results From the CEPHEUS study in Arabian Gulf countries JO - Angiology. VL - 65 UR - https://doi.org/10.1177/0003319713512414 DO - 10.1177/0003319713512414 ID - Arafah2014 ER - TY - JOUR AU - Jacobson, T. A. AU - Ito, M. K. AU - Maki, K. C. PY - 2014 DA - 2014// TI - National lipid association recommendations for patient-centered management of dyslipidemia: part 1. Executive summary JO - J Clin Lipidol. VL - 8 UR - https://doi.org/10.1016/j.jacl.2014.07.007 DO - 10.1016/j.jacl.2014.07.007 ID - Jacobson2014 ER - TY - JOUR AU - Alberti, K. G. AU - Eckel, R. H. AU - Grundy, S. M. PY - 2009 DA - 2009// TI - Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity JO - Circulation VL - 120 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.192644 DO - 10.1161/CIRCULATIONAHA.109.192644 ID - Alberti2009 ER - TY - JOUR AU - James, P. A. AU - Oparil, S. AU - Carter, B. L. PY - 2014 DA - 2014// TI - 2014 evidence-based guideline for the management of high blood pressure in adults: report from panel members appointed to the Eighth Joint National Committee (JNC 8) JO - JAMA VL - 311 UR - https://doi.org/10.1001/jama.2013.284427 DO - 10.1001/jama.2013.284427 ID - James2014 ER - TY - JOUR AU - Reaven, G. M. PY - 1993 DA - 1993// TI - Role of insulin resistance in human disease (syndrome X): an expanded definition JO - Annu Rev Med VL - 44 UR - https://doi.org/10.1146/annurev.me.44.020193.001005 DO - 10.1146/annurev.me.44.020193.001005 ID - Reaven1993 ER - TY - JOUR AU - Eckel, R. H. AU - Grundy, S. M. AU - Zimmet, P. Z. PY - 2005 DA - 2005// TI - The metabolic syndrome JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66378-7 DO - 10.1016/S0140-6736(05)66378-7 ID - Eckel2005 ER - TY - JOUR AU - Assmann, G. AU - Schulte, H. PY - 1992 DA - 1992// TI - Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience) JO - Am J Cardiol VL - 70 UR - https://doi.org/10.1016/0002-9149(92)90550-I DO - 10.1016/0002-9149(92)90550-I ID - Assmann1992 ER - TY - JOUR AU - Austin, M. A. PY - 1998 DA - 1998// TI - Plasma triglyceride as a risk factor for cardiovascular disease JO - Can J Cardiol VL - 14 ID - Austin1998 ER - TY - JOUR AU - Gordon, D. J. AU - Probstfield, J. L. AU - Garrison, R. J. PY - 1989 DA - 1989// TI - High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies JO - Circulation VL - 79 UR - https://doi.org/10.1161/01.CIR.79.1.8 DO - 10.1161/01.CIR.79.1.8 ID - Gordon1989 ER - TY - JOUR AU - Mottillo, S. AU - Filion, K. B. AU - Genest, J. PY - 2010 DA - 2010// TI - The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis JO - J Am Coll Cardiol VL - 56 UR - https://doi.org/10.1016/j.jacc.2010.05.034 DO - 10.1016/j.jacc.2010.05.034 ID - Mottillo2010 ER - TY - JOUR AU - Reaven, G. M. PY - 1991 DA - 1991// TI - Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease JO - Am Heart J VL - 121 UR - https://doi.org/10.1016/0002-8703(91)90434-J DO - 10.1016/0002-8703(91)90434-J ID - Reaven1991 ER - TY - JOUR AU - Lamarche, B. AU - Tchernof, A. G. AU - Moorjani, S. PY - 1997 DA - 1997// TI - Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec cardiovascular study JO - Circulation VL - 95 UR - https://doi.org/10.1161/01.CIR.95.1.69 DO - 10.1161/01.CIR.95.1.69 ID - Lamarche1997 ER - TY - JOUR AU - Adeli, K. AU - Taghibiglou, C. AU - Iderstine, S. C. PY - 2001 DA - 2001// TI - Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance JO - Trends Cardiovasc Med VL - 11 UR - https://doi.org/10.1016/S1050-1738(01)00084-6 DO - 10.1016/S1050-1738(01)00084-6 ID - Adeli2001 ER - TY - JOUR AU - Karpe, F. AU - Tornwall, P. AU - Olivecrona, T. PY - 1993 DA - 1993// TI - Composition of human low density: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein JO - Atherosclerosis. VL - 98 UR - https://doi.org/10.1016/0021-9150(93)90221-F DO - 10.1016/0021-9150(93)90221-F ID - Karpe1993 ER - TY - JOUR AU - Mudd, J. O. AU - Borlaug, B. A. AU - Johnston, P. V. PY - 2007 DA - 2007// TI - Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease JO - J Am Coll Cardiol VL - 50 UR - https://doi.org/10.1016/j.jacc.2007.07.045 DO - 10.1016/j.jacc.2007.07.045 ID - Mudd2007 ER - TY - JOUR AU - Tato, F. AU - Vega, G. L. AU - Grundy, S. M. PY - 1997 DA - 1997// TI - Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients: role of cholesterol-ester-transfer protein and lecithin cholesteryl acyl transferase JO - Arterioscler Tromb Vasc Biol. VL - 17 UR - https://doi.org/10.1161/01.ATV.17.1.56 DO - 10.1161/01.ATV.17.1.56 ID - Tato1997 ER - TY - JOUR AU - Ginsberg, H. N. PY - 1996 DA - 1996// TI - Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels JO - Diabetes VL - 45 UR - https://doi.org/10.2337/diab.45.3.S27 DO - 10.2337/diab.45.3.S27 ID - Ginsberg1996 ER - TY - JOUR AU - Festa, A. AU - D’Agostino, R. AU - Howard, G. PY - 2000 DA - 2000// TI - Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS) JO - Circulation VL - 102 UR - https://doi.org/10.1161/01.CIR.102.1.42 DO - 10.1161/01.CIR.102.1.42 ID - Festa2000 ER - TY - JOUR AU - Barzilay, J. I. AU - Abraham, L. AU - Heckbert, S. R. PY - 2001 DA - 2001// TI - The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study JO - Diabetes VL - 50 UR - https://doi.org/10.2337/diabetes.50.10.2384 DO - 10.2337/diabetes.50.10.2384 ID - Barzilay2001 ER - TY - JOUR AU - Pradhan, A. D. AU - Manson, J. E. AU - Rifai, N. PY - 2001 DA - 2001// TI - C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JO - JAMA VL - 286 UR - https://doi.org/10.1001/jama.286.3.327 DO - 10.1001/jama.286.3.327 ID - Pradhan2001 ER - TY - JOUR AU - Ridker, P. M. AU - Buring, J. E. AU - Cook, N. R. AU - Rifai, N. PY - 2003 DA - 2003// TI - Creactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women JO - Circulation VL - 107 ID - Ridker2003 ER - TY - JOUR AU - Grundy, S. M. PY - 2012 DA - 2012// TI - Pre-diabetes, metabolic syndrome, and cardiovascular risk JO - J Am Coll Cardiol VL - 59 UR - https://doi.org/10.1016/j.jacc.2011.08.080 DO - 10.1016/j.jacc.2011.08.080 ID - Grundy2012 ER - TY - JOUR AU - Panel, E. D. AU - Grundy, S. M. PY - 2014 DA - 2014// TI - An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia JO - J Clin Lipid. VL - 8 ID - Panel2014 ER - TY - JOUR AU - Reiner, Z. AU - Catapano, A. L. AU - DeBacker, G. PY - 2011 DA - 2011// TI - ESC/EAS guidelines for the management of dyslipidemias—The task force for the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) JO - Eur Heart J VL - 32 ID - Reiner2011 ER - TY - JOUR PY - 2014 DA - 2014// TI - Standards of medical care in diabetes–2014 JO - Diabetes Care VL - 37 UR - https://doi.org/10.2337/dc14-S014 DO - 10.2337/dc14-S014 ID - ref31 ER - TY - JOUR AU - Deedwania, P. AU - Barter, P. AU - Carmena, R. PY - 2006 DA - 2006// TI - Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the treating to new targets study JO - Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69292-1 DO - 10.1016/S0140-6736(06)69292-1 ID - Deedwania2006 ER - TY - JOUR AU - Pyorala, K. AU - Ballantyne, C. M. AU - Gumbiner, B. PY - 2004 DA - 2004// TI - Reduction of cardiovascular events by simavastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.7.1735 DO - 10.2337/diacare.27.7.1735 ID - Pyorala2004 ER - TY - JOUR AU - Downs, J. R. AU - Clearfield, M. AU - Weis, S. PY - 1998 DA - 1998// TI - For the Air Force/Texas Coronary Atherosclerosis Prevention Study—primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS JO - JAMA VL - 279 UR - https://doi.org/10.1001/jama.279.20.1615 DO - 10.1001/jama.279.20.1615 ID - Downs1998 ER - TY - JOUR PY - 2003 DA - 2003// TI - Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial JO - Circulation VL - 108 UR - https://doi.org/10.1161/01.CIR.0000100688.17280.E6 DO - 10.1161/01.CIR.0000100688.17280.E6 ID - ref35 ER - TY - JOUR AU - Cannon, C. P. AU - Blazing, M. A. AU - Giugliano, R. P. PY - 2015 DA - 2015// TI - Ezetimibe added to statin therapy after acute coronary syndromes JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1410489 DO - 10.1056/NEJMoa1410489 ID - Cannon2015 ER - TY - JOUR AU - Keene, D. AU - Price, C. AU - Shun-Shin, M. J. AU - Francis, D. P. PY - 2014 DA - 2014// TI - Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients JO - BMJ VL - 349 UR - https://doi.org/10.1136/bmj.g4379 DO - 10.1136/bmj.g4379 ID - Keene2014 ER - TY - JOUR AU - Robins, S. J. AU - Bloomfield, H. E. PY - 2006 DA - 2006// TI - Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials JO - Curr Opin Lipidol VL - 17 ID - Robins2006 ER - TY - JOUR AU - Sacks, F. M. AU - Carey, V. J. AU - Fruchart, J. C. PY - 2010 DA - 2010// TI - Combination lipid therapy in type 2 diabetes JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMc1006407 DO - 10.1056/NEJMc1006407 ID - Sacks2010 ER - TY - JOUR AU - Wang, F. AU - Ye, P. AU - Hu, D. AU - Min, Y. AU - Zhao, S. AU - Wang, Y. PY - 2014 DA - 2014// TI - Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: a subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China) JO - Atherosclerosis. VL - 237 ID - Wang2014 ER - TY - JOUR AU - Chen, C. Y. AU - Chuang, S. Y. AU - Fang, C. C. PY - 2014 DA - 2014// TI - Gender disparities in optimal lipid control among patients with coronary artery disease JO - J Atheroscler Thromb. VL - 21 UR - https://doi.org/10.5551/jat.21_Sup.1-S20 DO - 10.5551/jat.21_Sup.1-S20 ID - Chen2014 ER - TY - JOUR AU - Faharani, P. PY - 2014 DA - 2014// TI - Gender gap in lipid management amongst diabetes population: an observation JO - J Popul Ther Clin Pharmacol. VL - 21 ID - Faharani2014 ER - TY - JOUR AU - Magee, M. F. AU - Tamis-Holland, J. E. AU - Lu, J. PY - 2015 DA - 2015// TI - Sex, prescribing practices and guideline recommended, blood pressure, and LDL cholesterol targets at baseline in the BARI 2D trial JO - Int J Endocrinol. VL - 2015 UR - https://doi.org/10.1155/2015/610239 DO - 10.1155/2015/610239 ID - Magee2015 ER -